SCMP Share Price |
||||
| Open | 9.60 | Change | Price | % |
| High | 10.10 | 1 Day | 0.50 | 5.26 |
| Low | 9.60 | 1 Week | 0.00 | 0.00 |
| Close | 10.00 | 1 Month | -0.20 | -1.96 |
| Volume | 816748 | 1 Year | -5.20 | -34.21 |
| 52 Week High 17.55 | ||||
| 52 Week Low 9.30 | ||||
| SCMP Important Levels | |
| Resistance 2 | 10.46 |
| Resistance 1 | 10.27 |
| Pivot | 9.90 |
| Support 1 | 9.73 |
| Support 2 | 9.54 |
| NASDAQ USA Most Active Stocks | |||
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| YHOO | 52.58 | 0.00% | |
| FNFG | 10.18 | -0.20% | |
| DELL | 13.86 | 0.22% | |
| RFMD | 16.59 | -2.07% | |
| MU | 44.31 | 6.39% | |
| MU | 44.31 | 6.39% | |
| MU | 44.31 | 6.39% | |
| RIMM | 13.03 | 0.39% | |
| NASDAQ USA Top Gainers Stocks | |||
| LOCM | 0.09 | 50.00% | |
| SCHS | 0.04 | 33.33% | |
| BSDM | 0.62 | 26.53% | |
| SNTA | 0.34 | 25.93% | |
| HLIT | 3.70 | 25.42% | |
| OTT | 2.39 | 25.13% | |
| QNST | 8.90 | 20.76% | |
| VRTA | 4.00 | 19.40% | |
| SNSS | 2.56 | 19.07% | |
| GCFB | 0.44 | 18.92% | |
| NASDAQ USA Top Losers Stocks | |||
| TXCC | 0.01 | -95.00% | |
| GMETP | 0.15 | -76.92% | |
| HCIIP | 10.10 | -67.52% | |
| CRMB | 0.27 | -57.81% | |
| KIOR | 0.03 | -57.14% | |
| OSH | 0.26 | -49.02% | |
| OSH | 0.26 | -49.02% | |
| DVOX | 0.05 | -44.44% | |
| PRXI | 0.21 | -43.24% | |
| TRGT | 0.96 | -41.46% | |
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP)
| SCMP Technical Analysis | 5 |
| As on 31st Oct 2017 SCMP Share Price closed @ 10.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.34 & Strong Sell for SHORT-TERM with Stoploss of 11.12 we also expect STOCK to react on Following IMPORTANT LEVELS. | |
| SCMP Target for April | |
| 1st Target up-side | 11.44 |
| 2nd Target up-side | 12.46 |
| 3rd Target up-side | 13.47 |
| 1st Target down-side | 8.56 |
| 2nd Target down-side | 7.54 |
| 3rd Target down-side | 6.53 |
Sucampo Pharmaceuticals, Inc. ( NASDAQ USA Symbol : SCMP ) Sector : Healthcare And Other Stocks in Same Sector |
|||||
|
ABAX
48.40 0.54 (1.13 %) LT : Sell ST : Buy |
ABIO
1.21 0.01 (0.83 %) LT : Strong Sell ST : Sell |
ABMD
192.92 13.44 (7.49 %) LT : Strong Buy ST : Strong Buy |
ACAD
34.83 -0.35 (-0.99 %) LT : Buy ST : Sell |
ACHC
31.36 0.03 (0.10 %) LT : Strong Sell ST : Strong Sell |
|
|
|
||||||||||||||||||||||
|
Interactive Technical Analysis Chart Sucampo Pharmaceuticals, Inc. ( SCMP NASDAQ USA )
Your Comments and Response on Sucampo Pharmaceuticals, Inc.
SCMP Business Profile
Sucampo Pharmaceuticals, Inc. is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�s prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�s products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl). AMITIZA is marketed in the United States for three gastrointestinal indications: chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.